Making medications more affordable to patients is linked to better adherence, with no added costs, according to a new study.
Pharmacy Best Practices
Not all therapies work the same in every patient, but that’s not the biggest challenge in treating mental health. This is.
In response to the lack of transparency, health organizations are creating drug pricing tools that deliver patient-specific pricing. Here’s how they work.
A new forecast reveals an important focus point for healthcare execs in the quest to manage pharma costs.
Here are four other things that MCOs should know about a first-of-its kind targeted RNA-based therapy to treat a rare disease.
Although the act would not prohibit manufacturers from increasing prices, it could change the pricing landscape. Here’s why.
Managed Healthcare Executive asked key opinion leaders their thoughts on the drug rebate controversy. Here’s what they said.
When it comes to promising areas in the treatment of lymphoma and other blood cancers, gene therapy may be at the top of the list. Here’s why.
Are recent pharma price drops just a response to political pressure or will the momentum last? Managed Healthcare Executive asked industry experts, and here’s what they said.
Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.